Megestrol acetate/Medroxyprogesterone acetate clinical trials

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

This study is testing a new medicine, MK-5684, for breast, ovarian, and endometrial cancers. It aims to see if MK-5684, which blocks steroid hormones, can stop cancer from growing or spreading for longer than current standard treatments.